{
    "2019-02-21": [
        [
            {
                "time": "2018-12-31",
                "original_text": "受益于投资收益 沃森生物2018年净利润增长近3倍",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利润",
                        "投资收益",
                        "增长近3倍"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "沃森生物2018年净利同比增长294%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利",
                        "同比增长294%"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "沃森生物：2018年净利10.46亿元 实现扭亏为盈",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利10.46亿元",
                        "扭亏为盈"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "沃森生物：2018年净利润10.5亿元 较上年同期增加3倍",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利润10.5亿元",
                        "增加3倍"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "沃森生物(300142.SZ)2018年度业绩扭亏为盈至10.46亿元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "300142.SZ",
                        "业绩扭亏为盈",
                        "10.46亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}